Literature DB >> 11971089

Neuropsychiatric syndromes in lupus: prevalence using standardized definitions.

R L Brey1, S L Holliday, A R Saklad, M G Navarrete, D Hermosillo-Romo, C L Stallworth, C R Valdez, A Escalante, I del Rincón, G Gronseth, C B Rhine, P Padilla, D McGlasson.   

Abstract

OBJECTIVE: The San Antonio Lupus Study of Neuropsychiatric Disease is a longitudinal study designed to characterize the spectrum of and important risk factors for specific neuropsychiatric systemic lupus erythematosus (NPSLE) syndromes.
METHODS: Subjects must meet criteria for SLE and must be at least 18 years of age. A standardized medical history, neurologic, rheumatologic, and psychiatric examinations, computerized neuropsychological evaluation, and serologic testing are performed.
RESULTS: This report is based on the first 128 subjects (120 women and 8 men) who completed the initial study visit. Data from this initial study visit were evaluated for the prevalence of NPSLE using the American College of Rheumatology case definitions for 19 NPSLE syndromes. One or more NPSLE syndromes were present in 80% of subjects: cerebrovascular disease (2, 2%; ischemic stroke); headaches (73, 57%); mononeuropathy (9, 8%; median 8, ulnar 1); movement disorder (1, 1%; chorea); neuropathy, cranial (2, 2%; trigeminal); polyneuropathy (29, 22%; sensorimotor); seizures (21, 16%; partial); anxiety disorder (27, 24%); major depressive-like episode (37, 28%); mood disorder with depressive features (21, 19%); mood disorder with manic features (3, 3%); mood disorder with mixed features (1, 1%); psychosis (6, 5%). In a subset of 67 patients who received standardized neuropsychological testing, 21% had normal results. In the remainder, the following levels of impairment were seen: 43% mild, 30% moderate, and 6% severe.
CONCLUSIONS: The prevalence of NPSLE was high in this cohort of unselected patients with SLE. Headaches, cognitive dysfunction, and psychiatric disorders were the most common NPSLE syndromes seen. These results will be easily comparable to other studies also using standardized diagnostic criteria. However, the lack of ethnicity and language-matched normative neuropsychological data may make comparisons of cognitive dysfunction in SLE populations difficult.

Entities:  

Mesh:

Year:  2002        PMID: 11971089     DOI: 10.1212/wnl.58.8.1214

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  131 in total

1.  Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms.

Authors:  Thomas W Faust; Eric H Chang; Czeslawa Kowal; RoseAnn Berlin; Irina G Gazaryan; Eva Bertini; Jie Zhang; Jorge Sanchez-Guerrero; Hilda E Fragoso-Loyo; Bruce T Volpe; Betty Diamond; Patricio T Huerta
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-04       Impact factor: 11.205

Review 2.  Ethnic disparities in patients with systemic lupus erythematosus.

Authors:  América G Uribe; Graciela S Alarcón
Journal:  Curr Rheumatol Rep       Date:  2003-10       Impact factor: 4.592

3.  Fatigue in systemic lupus erythematosus.

Authors:  Grace E Ahn; Rosalind Ramsey-Goldman
Journal:  Int J Clin Rheumtol       Date:  2012-04-01

Review 4.  Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies.

Authors:  Emilia H Moscato; Ankit Jain; Xiaoyu Peng; Ethan G Hughes; Josep Dalmau; Rita J Balice-Gordon
Journal:  Eur J Neurosci       Date:  2010-07-14       Impact factor: 3.386

5.  Reduced Insular Glutamine and N-acetylaspartate in systemic lupus erythematosus: a single-voxel (1)H-MR spectroscopy study.

Authors:  Patricia Cagnoli; Richard E Harris; Dan Frechtling; George Berkis; Richard H Gracley; Courtney C Graft; Suzan E Lowe; Thomas L Chenevert; William J McCune; Stephen Gebarski; Pia C Sundgren
Journal:  Acad Radiol       Date:  2013-10       Impact factor: 3.173

6.  Effectiveness of olanzapine for systemic lupus erythematosus-related psychosis.

Authors:  Joel P Pinto; Silvio Luiz Morais; Jaime E C Hallak; Serdar M Dursun
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2006

Review 7.  Notes on the kidney and its diseases for the neurologist.

Authors:  Michael S Zandi; Alasdair J Coles
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-05       Impact factor: 10.154

Review 8.  Neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  David Hermosillo-Romo; Robin L Brey
Journal:  Curr Rheumatol Rep       Date:  2002-08       Impact factor: 4.592

Review 9.  Cognitive impairment in elderly patients with rheumatic disease and the effect of disease-modifying anti-rheumatic drugs.

Authors:  Akhil Sood; Mukaila A Raji
Journal:  Clin Rheumatol       Date:  2020-08-30       Impact factor: 2.980

Review 10.  Corticosteroid-induced neuropsychiatric disorders: review and contrast with neuropsychiatric lupus.

Authors:  Samir D Bhangle; Neil Kramer; Elliot D Rosenstein
Journal:  Rheumatol Int       Date:  2013-04-16       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.